BPC-157 vs Collagen: What to Choose and for Whom

A person with pain in the Achilles tendon or knee often faces a choice: the “trendy” peptide BPC-157, talked about on forums, or ordinary collagen. The editorial team looked at typical scenarios and explains what studies show, how to use collagen rationally, and why BPC-157 should not be considered an alternative.
Where the dilemma comes from
Interest in BPC-157 is fueled by striking results in animals: accelerated healing of severed tendons, ligaments and muscles in rats. On social media these data are often presented as a proven effect in humans, although there are no clinical studies with published results.
Collagen, on the contrary, is perceived as a “boring” supplement, although it is precisely for it that there are randomized studies in humans with tendinopathy, joint pain and in strength-training programs.
The result is a paradox: a substance with minimal evidence is considered stronger, while a product with proven, if moderate, effects is considered weaker. The reason lies in the notion that an “injectable peptide” is automatically more effective than food.
To make an informed choice, it is worth examining the specific situations in which people seek help, and seeing what is known for each of them.
Scenarios: tendinopathy, joint pain, injury
Tendinopathy (for example, Achilles or patellar). The basis of treatment is progressive loading — eccentric or isometric exercises. Praet et al. (2019) showed that adding specific collagen peptides to a program of calf-muscle exercises improved function and reduced pain more than exercises with placebo.
Activity-related joint pain. In a 24-week study by Clark et al. (2008), athletes taking collagen hydrolysate reported less pain compared with placebo. The effect is moderate, and it does not replace diagnosis of the causes of pain.
Acute injury or rupture. Here the decisive factors are examination by a doctor, imaging and, if needed, surgical treatment. No supplement or peptide compensates for the wrong approach, and attempts at self-treatment can delay the time to needed intervention.
Loss of muscle mass in old age. Zdzieblik et al. (2015) showed that collagen peptides combined with strength training improved body composition and strength in older men with sarcopenia compared with placebo.
| Situation | Collagen | BPC-157 |
|---|---|---|
| Tendinopathy + exercise | RCT with a positive result | Only animal data |
| Joint pain during activity | Moderate effect in RCTs | No human data |
| Acute rupture | Only adjunct nutrition | Not studied in humans |
| Athlete under doping control | Permitted | Prohibited (WADA S0) |

How to use collagen according to studies
Since collagen is a dietary supplement, one can speak of practical parameters. Studies most often used from 5 to 15 g of collagen peptides or gelatin per day.
The protocol of Shaw et al. (2017) involved taking 15 g of gelatin together with 50 mg of vitamin C about an hour before a short jumping session. The logic is to have the peak of amino acids in the blood coincide with the period when the loaded tendon is actively synthesizing collagen.
Vitamin C is a cofactor of the enzymes that stabilize collagen fibers, so adding it is justified. Vitamin C deficiency is rare with a normal diet, but a small dose together with collagen does no harm.
The main practical principles:
- combine intake with rehabilitation or training exercises;
- take it 30–60 minutes before loading;
- add a source of vitamin C;
- assess the result after weeks or months, not days;
- choose products with independent certification if you are an athlete.
Why BPC-157 is not an alternative
The first reason is the absence of evidence in humans. The review by Gwyer et al. (2019) emphasizes that despite encouraging preclinical results, the efficacy and safety of BPC-157 in humans have not been established.
The second reason is an unknown safety profile. A peptide that stimulates angiogenesis and cell growth could theoretically be undesirable in the presence of hidden neoplasms. There are no long-term safety studies.
The third reason is product quality. BPC-157 is sold as a “research reagent,” without pharmaceutical control. Regulatory bodies, in particular the FDA, have drawn attention to the potential safety risks of this substance and the lack of data on it.
The fourth reason is sport. BPC-157 is included in the WADA Prohibited List in section S0, so for athletes any use of it may end in disqualification.
Which option is appropriate for whom
For people with tendinopathy, joint pain or in the process of rehabilitation, collagen can be a reasonable addition to an exercise program agreed with a physiotherapist or doctor.
For older people who do strength training, collagen peptides can help as an additional source of protein, although in amino-acid composition collagen is inferior to whey protein for muscle growth.
People allergic to fish or other raw-material sources should check the origin of the product, and those with kidney disease should agree any increase in protein intake with a doctor.
BPC-157 today cannot be recommended for any group of people outside the bounds of clinical studies. If an injury does not heal, the right step is a repeat consultation with a specialist, not a search for experimental agents.
Editorial conclusions
If choosing between BPC-157 and collagen, the rational choice is collagen combined with properly dosed loading. It has confirmation in human studies, a high safety profile and does not violate anti-doping rules.
BPC-157 remains an experimental substance with promising animal data, but without clinical evidence, quality control and with a WADA ban.
The main factor in the recovery of tendons and joints is not a supplement but competent rehabilitation under a specialist’s supervision.
We also advise reading our materials “BPC-157 or collagen: what is the difference,” on comparing data for TB-500 and BPC-157, and on collagen for ligaments and joints.
References
- Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976–983.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153–159.
- Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. 2017;105(1):136–143.
- Clark KL, Sebastianelli W, Flechsenhar KR, et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin. 2008;24(5):1485–1496.
- Praet SFE, Purdam CR, Welvaert M, et al. Oral supplementation of specific collagen peptides combined with calf-strengthening exercises enhances function and reduces pain in Achilles tendinopathy patients. Nutrients. 2019;11(1):76.
- Zdzieblik D, Oesser S, Baumstark MW, Gollhofer A, König D. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial. Br J Nutr. 2015;114(8):1237–1245.
- Khatri M, Naughton RJ, Clifford T, Harper LD, Corr L. The effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: a systematic review. Amino Acids. 2021;53(10):1493–1506.
- World Anti-Doping Agency. The World Anti-Doping Code International Standard: Prohibited List. Montreal: WADA; актуальна редакція.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.


